ArticleAnnals of the rheumatic diseases2021

Tenascin-C, a novel target to inhibit new bone formation in axial spondyloarthritis, linked with inflammation, mechanical strain and tissue damage.

Margot Van Mechelen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.